
SaiyanMedBPC-157
Ordered BPC-157 from SaiyanMed? Mail in a sample (US only) and let us test it.
Test my supplySaiyanMed's purity-focused record is strongest on Retatrutide's recent rebound and repeated high-purity Tesamorelin, with smaller clean signals for Melanotan II. The evidence is recent and broad but dispersed: Tirzepatide has a severe latest purity/fill/no-batch miss, while BPC-157 and GHK-Cu add failures and batch documentation remains mixed.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including SaiyanMed rows.
Cancel anytime
About SaiyanMed test results from Finnrick
SaiyanMed is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 51 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible SaiyanMed peptides in this dataset are Retatrutide (24 tests) and Melanotan II (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 51 recent tests.
Ordered BPC-157 from SaiyanMed? Mail in a sample (US only) and let us test it.
Test my supply